Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Current Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Current Liabilities for 2 consecutive years, with $35.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities changed N/A to $35.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was $35.8 million, a N/A change, with the full-year FY2025 number at $38.0 million, up 15.18% from a year prior.
  • Total Current Liabilities was $35.8 million for Q4 2025 at Kestra Medical Technologies, up from $32.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $38.7 million in Q1 2025 to a low of $32.3 million in Q3 2025.